serves as Chief Medical Officer and Deputy Director of the Joint Pathology Center (JPC) in Silver Spring, Maryland—formerly the Armed Forces Institute of Pathology. A molecular, genetic, and genitourinary pathologist, Dr. Moncur earned his MD from Dartmouth’s Geisel School of Medicine and both his MS and PhD from Dartmouth College.

Dr. Moncur previously served as Director of the Joint Pathology Center and as Chair of Pathology at Walter Reed National Military Medical Center. In 2020, he initiated the digital transformation of the JPC’s historic pathology repository—one of the nation’s largest—digitizing over 6 million glass slides and developing AI-ready datasets. His team’s work has supported prototype machine learning algorithms, including one that detects, grades, and predicts the prognosis of prostate cancer.

Dr. Moncur’s research spans molecular oncology and infectious diseases, with publications on the neuropathology of COVID-19, the pathology of measles as a re-emerging disease, and optimal testing for human papillomavirus in head and neck cancers.

Within the College of American Pathologists (CAP), Dr. Moncur serves on the Board of Governors, chairs the Council on Scientific Affairs, and is a member of both the Information Technology Leadership Committee and the Finance Committee. He previously chaired the CAP Molecular Oncology Committee and served as its advisor.

September 2021 CE Story and Test

Related

Blood culture contamination in U.S. hospitals

Dear API Abby

A Better Way to Manage Antinuclear Autoantibody Testing

Antinuclear Antibody Testing: How to Manage Loss of HEp-2 IFA Expertise

Trending

Inside the lab of 2026: Insights from 12 laboratory experts

Advancing laboratory excellence: An interview with the CAP’s Joel Todd Moncur, MD, PhD, MS, FCAP

What is my patient’s volume status? Leveraging plasma volume estimation to guide clinical decisions in and beyond the ICU

Sponsored Picks

A Better Way to Manage Antinuclear Autoantibody Testing

Antinuclear Antibody Testing: How to Manage Loss of HEp-2 IFA Expertise

Can Clinical Laboratories Improve Patient Care Without Increasing Cost?